Cargando…

Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP

Detalles Bibliográficos
Autores principales: Landauer, Karlheinz, Unutmaz, Cuneyt, Egli, Simon, Berger, Verena, Lais, Simone, Liebig, Timo, Steiner, Daniel, Maier, Jo, Rostalski, Ina, Forcellino, Francois, Herrmann, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284948/
https://www.ncbi.nlm.nih.gov/pubmed/22373224
http://dx.doi.org/10.1186/1753-6561-5-S8-P42
_version_ 1782224425303670784
author Landauer, Karlheinz
Unutmaz, Cuneyt
Egli, Simon
Berger, Verena
Lais, Simone
Liebig, Timo
Steiner, Daniel
Maier, Jo
Rostalski, Ina
Forcellino, Francois
Herrmann, Andreas
author_facet Landauer, Karlheinz
Unutmaz, Cuneyt
Egli, Simon
Berger, Verena
Lais, Simone
Liebig, Timo
Steiner, Daniel
Maier, Jo
Rostalski, Ina
Forcellino, Francois
Herrmann, Andreas
author_sort Landauer, Karlheinz
collection PubMed
description
format Online
Article
Text
id pubmed-3284948
institution National Center for Biotechnology Information
language English
publishDate 2011
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-32849482012-02-23 Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP Landauer, Karlheinz Unutmaz, Cuneyt Egli, Simon Berger, Verena Lais, Simone Liebig, Timo Steiner, Daniel Maier, Jo Rostalski, Ina Forcellino, Francois Herrmann, Andreas BMC Proc Meeting Abstract BioMed Central 2011-11-22 /pmc/articles/PMC3284948/ /pubmed/22373224 http://dx.doi.org/10.1186/1753-6561-5-S8-P42 Text en Copyright ©2011 Landauer et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Meeting Abstract
Landauer, Karlheinz
Unutmaz, Cuneyt
Egli, Simon
Berger, Verena
Lais, Simone
Liebig, Timo
Steiner, Daniel
Maier, Jo
Rostalski, Ina
Forcellino, Francois
Herrmann, Andreas
Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
title Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
title_full Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
title_fullStr Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
title_full_unstemmed Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
title_short Process development of ATROSAB, an anti TNFR1 Monoclonal Antibody: in three steps from research to GMP
title_sort process development of atrosab, an anti tnfr1 monoclonal antibody: in three steps from research to gmp
topic Meeting Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3284948/
https://www.ncbi.nlm.nih.gov/pubmed/22373224
http://dx.doi.org/10.1186/1753-6561-5-S8-P42
work_keys_str_mv AT landauerkarlheinz processdevelopmentofatrosabanantitnfr1monoclonalantibodyinthreestepsfromresearchtogmp
AT unutmazcuneyt processdevelopmentofatrosabanantitnfr1monoclonalantibodyinthreestepsfromresearchtogmp
AT eglisimon processdevelopmentofatrosabanantitnfr1monoclonalantibodyinthreestepsfromresearchtogmp
AT bergerverena processdevelopmentofatrosabanantitnfr1monoclonalantibodyinthreestepsfromresearchtogmp
AT laissimone processdevelopmentofatrosabanantitnfr1monoclonalantibodyinthreestepsfromresearchtogmp
AT liebigtimo processdevelopmentofatrosabanantitnfr1monoclonalantibodyinthreestepsfromresearchtogmp
AT steinerdaniel processdevelopmentofatrosabanantitnfr1monoclonalantibodyinthreestepsfromresearchtogmp
AT maierjo processdevelopmentofatrosabanantitnfr1monoclonalantibodyinthreestepsfromresearchtogmp
AT rostalskiina processdevelopmentofatrosabanantitnfr1monoclonalantibodyinthreestepsfromresearchtogmp
AT forcellinofrancois processdevelopmentofatrosabanantitnfr1monoclonalantibodyinthreestepsfromresearchtogmp
AT herrmannandreas processdevelopmentofatrosabanantitnfr1monoclonalantibodyinthreestepsfromresearchtogmp